Internal Medicine, Hematology & Oncology · San Diego, CA
NPI
1841223617
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
200 W Arbor Dr
San Diego, CA, 92103
Phone (858) 822-6276
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
194 services
Medicare patients, 2024
72
Average age 75
Drug cost, 2024
$6.4M
536 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Catriona Jamieson was code 99214 (office e&m - established), 185 times for 72 patients. In total Catriona Jamieson billed 194 services in 3 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 185 | 72 | $73.72 | $14K |
By year: 2022 $15K for 199 services; 2023 $15K for 200 services; 2024 $15K for 194 services.
Medicare prescription drug claims, 2024
In 2024, the drug Catriona Jamieson prescribed most often to Medicare patients was Inrebic (Fedratinib Dihydrochloride), with 248 prescriptions and refills. In total Catriona Jamieson wrote 536 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Inrebic Fedratinib Dihydrochloride | 248 | 249 | 27 | $4.8M |
| Jakafi Ruxolitinib Phosphate | 82 | 82 | 11 | $1.2M |
| Pegasys Peginterferon Alfa-2a | 49 | 55 | Under 11 | $140K |
| Hydroxyurea Generic | 43 | 89 | 13 | $1,080 |
| Azithromycin Generic | 26 | 26 | 11 | $115 |
| Allopurinol Generic | 25 | 46 | Under 11 | $110 |
| Eliquis Apixaban | 16 | 33 | Under 11 | $19K |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $37K |
Brand drugs: 415 claims; generic drugs: 121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Catriona Jamieson $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.